Overview

Memantine Augmentation in Obsessive-Compulsive Disorder

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether memantine is safe and effective when used as an augmentation to standard treatment for Obsessive-Compulsive Disorder (OCD).
Phase:
Phase 1/Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Stanford University
Treatments:
Memantine
Criteria
Inclusion Criteria:

- at least 18 years of age

- suffering from OCD

- Y-BOCS score of 18 or greater

- taking a therapeutic dose of an anti-OCD medication specified in the protocol

Exclusion Criteria:

- diagnosed with a mental disorder other than OCD

- taking tiagabine or pregabalin

- having had a previous trial of memantine

- receiving therapy for OCD

- substance abuse in the last 6 months

- personality disorders sufficiently severe to interfere with study participation